From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Tom Winnifrith Bearcast: Will Asimilar be the much deserved Waterloo of Chris Akers? This stinks!

By Tom Winnifrith | Tuesday 25 August 2020


Disclosure: I own shares in one or more of the stocks mentioned. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


I start with a brief discussion of Rule Britannia where it is clear that the BBC and others (including the Mrs) have not actually read the words or studied their history. I will do a much longer piece on this when back from seeing my father in Shipston. I look at Asimilar (ASLR), All Active Asset Capital (AAA), Mesh PLC, and Chris Akers – a scandal where the unravel is surely underway. I comment on DFS (DFS) and furlough economics, on Iconic Labs (ICON), and on Amigo (AMGO) as well as on Xtract Resources (XTR), where there is yet more good news making you who followed my tip and I who bought shares even richer. Also covered is NoGold who has no gold exposure and lambasts me for tipping gold shares and making you all richer… even more of a miserable old git.

You must be a paid subscriber to listen to Bearcast
ShareProphets is reader-supported journalism

Join us for free and gain access to three articles per month

Or become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

VCP

Victoria - The roll up unravels

 

HEMO

Hemogenyx is a short – target 0p

 

ECR

ECR, the timing is unfortunate

 

APH

Alliance Pharma – a recovery Buy?

 

PICH

Pitch Pit – this stinks

 

GEX

Georgina Energy: Lyin’ Yet again

Time left: 06:38:58